Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.

Toon andere (1) versies

BACKGROUND: Neuromyelitis optica (NMO) is a severe autoimmune inflammatory disorder associated with considerable relapse-related disability. Immunosuppression is the mainstay of treatment but many patients do not tolerate first-line immunosuppressive agents, or experience ongoing relapses. OBJECTIV...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Kitley, J, Elsone, L, George, J, Waters, P, Woodhall, M, Vincent, A, Jacob, A, Leite, M, Palace, J
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2013

Gelijkaardige items

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
door: Kitley, J, et al.
Gepubliceerd in: (2013)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
door: Kitley, J, et al.
Gepubliceerd in: (2012)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
door: Kitley, J, et al.
Gepubliceerd in: (2013)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
door: Elsone, L, et al.
Gepubliceerd in: (2012)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
door: Kitley, J, et al.
Gepubliceerd in: (2013)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
door: Kitley, J, et al.
Gepubliceerd in: (2014)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
door: Kitley, J, et al.
Gepubliceerd in: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
door: Kitley, J, et al.
Gepubliceerd in: (2014)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
door: Waters, P, et al.
Gepubliceerd in: (2015)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
door: Waters, P, et al.
Gepubliceerd in: (2016)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
door: Kitley, J, et al.
Gepubliceerd in: (2012)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
door: Kitley, J, et al.
Gepubliceerd in: (2012)

Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
door: Elsone, L, et al.
Gepubliceerd in: (2014)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
door: Leite, M, et al.
Gepubliceerd in: (2009)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
door: Nour, M, et al.
Gepubliceerd in: (2015)

Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom
door: Elsone, L, et al.
Gepubliceerd in: (2013)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
door: Kim, S, et al.
Gepubliceerd in: (2013)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
door: Kitley, J, et al.
Gepubliceerd in: (2012)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
door: Waters, P, et al.
Gepubliceerd in: (2008)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
door: Kitley, J, et al.
Gepubliceerd in: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
door: Kitley, J, et al.
Gepubliceerd in: (2014)

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
door: Wilson, R, et al.
Gepubliceerd in: (2018)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
door: Paul, F, et al.
Gepubliceerd in: (2007)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
door: Kitley, J, et al.
Gepubliceerd in: (2011)

PREGNANCY OUTCOME IN AQUAPORIN-4 POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER: A MULTI-CENTER RETROSPECTIVE COHORT STUDY
door: Nour, M, et al.
Gepubliceerd in: (2014)

Risk factors for immunosuppression-associated infections in aquaporin-4 antibody mediated neuromyelitis optica spectrum disorders
door: Cheng, F, et al.
Gepubliceerd in: (2014)

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
door: Min, J, et al.
Gepubliceerd in: (2010)

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
door: Palace, J, et al.
Gepubliceerd in: (2010)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
door: Jarius, S, et al.
Gepubliceerd in: (2008)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
door: Nour, M, et al.
Gepubliceerd in: (2014)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
door: Jarius, S, et al.
Gepubliceerd in: (2008)

MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS
door: Kitley, J, et al.
Gepubliceerd in: (2012)

Long term efficacy, adherence and reasons for discontinuation in 103 cases of neuromyelitis optica treated with azathioprine: a multicentre study from the United Kingdom
door: Elsone, L, et al.
Gepubliceerd in: (2013)

Use of mitoxantrone in neuromyelitis optica.
door: Kitley, J, et al.
Gepubliceerd in: (2011)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
door: Collongues, N, et al.
Gepubliceerd in: (2013)

Seasonal pattern of variation in neuromyelitis optica relapses
door: Elsone, L, et al.
Gepubliceerd in: (2012)

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G
door: Kim, S-M, et al.
Gepubliceerd in: (2016)

Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
door: Cavus, F, et al.
Gepubliceerd in: (2013)

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G
door: Kim, S-M, et al.
Gepubliceerd in: (2017)

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
door: Waters, P, et al.
Gepubliceerd in: (2008)